In a study, blocking the immune system complement protein C3 was shown to reduce MS disease severity in older mice but not in ...
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...